[Federal Register Volume 85, Number 62 (Tuesday, March 31, 2020)]
[Notices]
[Page 17868]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06690]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting; Modification

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting; modification.

-----------------------------------------------------------------------

SUMMARY: On February 26, 2020, the DoD published a notice to announce 
the April 1, 2020 meeting of the Uniform Formulary Beneficiary Advisory 
Panel. On March 9, 2020, the DoD published a notice that announced that 
the meeting time had changed. DoD is publishing this notice to announce 
that this federal advisory committee meeting has been modified to a 
remote access format.

DATES: Open to the public Wednesday, April 1, 2020 from 12:00 p.m. to 
3:00 p.m.

ADDRESSES: The address of the open meeting will be online. The phone 
number for the remote access is: CONUS: 888-469-2037; OCONUS: 1-517-
308-9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in 
instructions will also be posted on the Uniform Formulary Beneficiary 
Advisory Panel website at: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel.

FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice), None (Facsimile), [email protected] (Email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel. The most up-to-date 
changes to the meeting agenda can be found on the website.

SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of 
the Department of Defense, the Designated Federal Officer for the 
Uniform Formulary Beneficiary Advisory Panel was unable to provide 
public notification required by 41 CFR 102-3.150(a) concerning the 
modification of the previously noticed meeting for April 1, 2020. 
Accordingly, the Advisory Committee Management Officer for the 
Department of Defense, pursuant to 41 CFR 102-3.150(b), waives the 15-
calendar day notification requirement.
    On February 26, 2020 (85 FR 11053-11054), the Department of Defense 
published a notice that announced an April 1, 2020 meeting of the 
Uniform Formulary Beneficiary Advisory Panel. On March 9, 2020 (85 FR 
13636), the DoD published a notice that announced that the meeting time 
had changed. DoD is publishing this notice to announce that this 
federal advisory committee meeting has been modified to a remote access 
format.
    Written Statements: Pursuant to 41 CFR 102-3.10, and section 
10(a)(3) of FACA, interested persons or organizations may submit 
written statements to the Uniform Formulary Beneficiary Advisory Panel 
about its mission and/or the agenda to be addressed in this public 
meeting. Written statements should be submitted to the Uniform 
Formulary Beneficiary Advisory Panel's DFO. The DFO's contact 
information can be found in the FOR FURTHER INFORMATION CONTACT section 
of this notice. Written comments or statements must be received by the 
Uniform Formulary Beneficiary Advisory Panel's DFO at least five (5) 
business days prior to the meeting so they may be made available to the 
Uniform Formulary Beneficiary Advisory Panel for its consideration 
prior to the meeting. The Designated Federal Officer will review all 
submitted written statements and provide copies to all Uniform 
Formulary Beneficiary Advisory Panel members.

    Dated: March 26, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2020-06690 Filed 3-30-20; 8:45 am]
BILLING CODE 5001-06-P